These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23095969)

  • 81. Ascorbic acid, corticosteroids, and thiamine in sepsis: a review of the biologic rationale and the present state of clinical evaluation.
    Moskowitz A; Andersen LW; Huang DT; Berg KM; Grossestreuer AV; Marik PE; Sherwin RL; Hou PC; Becker LB; Cocchi MN; Doshi P; Gong J; Sen A; Donnino MW
    Crit Care; 2018 Oct; 22(1):283. PubMed ID: 30373647
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Critical care pharmacy in donor management.
    Phongsamran PV
    Prog Transplant; 2004 Jun; 14(2):105-11; quiz 112-3. PubMed ID: 15264455
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Pediatric considerations.
    Parker MM; Hazelzet JA; Carcillo JA
    Crit Care Med; 2004 Nov; 32(11 Suppl):S591-4. PubMed ID: 15542968
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The early antibiotic therapy in septic patients--milestone or sticking point?
    Bernhard M; Lichtenstern C; Eckmann C; Weigand MA
    Crit Care; 2014 Nov; 18(6):671. PubMed ID: 25672873
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Sepsis, a 2020 review for the internist.
    Purcarea A; Sovaila S
    Rom J Intern Med; 2020 Sep; 58(3):129-137. PubMed ID: 32396142
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Hydrocortisone in severe sepsis: time to accept the null hypothesis?
    Sanda RB; Omer OA
    South Med J; 2008 Sep; 101(9):972. PubMed ID: 18708964
    [No Abstract]   [Full Text] [Related]  

  • 87. [Intensive insulin therapy in sepsis. Improvement of survival chances?].
    Jeschke MG
    Anaesthesist; 2003 Dec; 52 Suppl 1():S20-3. PubMed ID: 14727047
    [No Abstract]   [Full Text] [Related]  

  • 88. Guidelines for treatment of sepsis.
    Kaspersen ER; Ræder J; Dahl V
    Tidsskr Nor Laegeforen; 2018 Feb; 138(4):. PubMed ID: 29460575
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Emerging drugs for the treatment of sepsis.
    Heming N; Lamothe L; Ambrosi X; Annane D
    Expert Opin Emerg Drugs; 2016; 21(1):27-37. PubMed ID: 26751198
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Improving Initial Sepsis Management Through a Nurse-Driven Rapid Response Team Protocol.
    Semanco M; Wright S; Rich RL
    Crit Care Nurse; 2022 Oct; 42(5):51-57. PubMed ID: 36180059
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Sepsis: a roadmap for future research.
    Cohen J; Vincent JL; Adhikari NK; Machado FR; Angus DC; Calandra T; Jaton K; Giulieri S; Delaloye J; Opal S; Tracey K; van der Poll T; Pelfrene E
    Lancet Infect Dis; 2015 May; 15(5):581-614. PubMed ID: 25932591
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Current strategies for managing the patient with sepsis.
    Kuhl DA
    Am J Health Syst Pharm; 2002 Feb; 59 Suppl 1():S9-13. PubMed ID: 11885413
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Novel approaches to the development of anti-sepsis drugs.
    Lehmann C; Sharawi N; Al-Banna N; Corbett N; Kuethe JW; Caldwell CC
    Expert Opin Drug Discov; 2014 May; 9(5):523-31. PubMed ID: 24697209
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Noteworthy Literature published in 2017 for Cardiac Critical Care.
    Ivascu NS; Shen L; Noguera E; Flynn BC
    Semin Cardiothorac Vasc Anesth; 2018 Mar; 22(1):18-26. PubMed ID: 29338605
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Pathogenic, immunologic, and clinical aspects of sepsis - update 2016.
    Uhle F; Chousterman BG; Grützmann R; Brenner T; Weber GF
    Expert Rev Anti Infect Ther; 2016 Oct; 14(10):917-27. PubMed ID: 27530423
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Reducing sepsis mortality.
    Lopez-Bushnell K; Demaray WS; Jaco C
    Medsurg Nurs; 2014; 23(1):9-14. PubMed ID: 24707663
    [No Abstract]   [Full Text] [Related]  

  • 97. [Treatment of infections in the critically ill under immunosuppression : What must be considered?].
    Salzberger B; Hitzenbichler F; Hanses F
    Z Rheumatol; 2019 Dec; 78(10):940-946. PubMed ID: 31538231
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Early Liberal Fluids for Sepsis Patients Are Harmful.
    Genga K; Russell JA
    Crit Care Med; 2016 Dec; 44(12):2258-2262. PubMed ID: 27058468
    [No Abstract]   [Full Text] [Related]  

  • 99. Optimal and responsible use of antibiotics.
    Depuydt P; De Waele JJ
    Curr Opin Crit Care; 2019 Oct; 25(5):458-464. PubMed ID: 31369410
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Myocardial calcifications following sepsis.
    Monnier-Cholley L; Roux A; Pacanowski J; Arrivé L
    Intensive Care Med; 2018 Jun; 44(6):981-982. PubMed ID: 29761215
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.